Yazid Fadl
Cardiovascular Disease · Greenwood Village, CONPI 1922014745
Payments from drug & device makers
Across 120 payments — averaging $28.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Artivion, Inc.$632
- Amgen$610
- Novo Nordisk$438
- Novartis$427
- Heartflow, Inc.$274
- Pfizer$141
- plus $930 from 17 others
What the payments were for
- Travel & lodging$33810%
- Food & beverage$3,07589%
- Education$391%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Artivion, Inc. | 2 | $632 |
| Amgen | 33 | $610 |
| Novo Nordisk | 16 | $438 |
| Novartis | 16 | $427 |
| Heartflow, Inc. | 6 | $274 |
| Pfizer | 7 | $141 |
| Cleerly, Inc. | 1 | $130 |
| Bayer | 5 | $107 |
| Lilly USA, LLC | 5 | $90 |
| Boehringer Ingelheim | 4 | $76 |
| Kiniksa Pharmaceuticals International, PLC | 4 | $72 |
| AstraZeneca | 4 | $70 |
| Alnylam Pharmaceuticals Inc. | 2 | $68 |
| Ionis Pharmaceuticals, Inc. | 2 | $67 |
| Bridgebio Pharma, Inc. | 2 | $48 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $45 |
| Esperion Therapeutics, Inc. | 2 | $36 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $30 |
| Abiomed | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22 |
| Lantheus Medical Imaging, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Johnson & Johnson | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- On-X$632
- FFRct$149
- Cleerly Ischemia$130
- Cleerly Labs$130
- Repatha$121
How this compares
$3,452 in reported general payments places this provider in the 60th percentile of 276 cardiovascular disease providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $101,779 |
| Repatha SureclickEvolocumab | 59 | $48,504 |
| XareltoRivaroxaban | 22 | $32,197 |
| Metoprolol Succinate | 161 | $2,850 |
| Rosuvastatin Calcium | 161 | $2,708 |
| Colchicine | 26 | $2,524 |
| Valsartan | 42 | $2,105 |
| Ezetimibe | 77 | $1,892 |
| Atorvastatin Calcium | 90 | $1,055 |
| Telmisartan | 20 | $643 |
| Lisinopril | 50 | $544 |
| Torsemide | 18 | $532 |
| Amlodipine Besylate | 74 | $460 |
| Losartan Potassium | 37 | $456 |
| ClopidogrelClopidogrel Bisulfate | 32 | $419 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $141 | $101,77981 claims |
| Johnson & JohnsonXarelto | $11 | $32,19722 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 276 cardiovascular disease providers in Colorado.
Other cardiovascular disease in Greenwood Village
- Jeffrey BooneGreenwood Village$287K
- Gary LuckasenFort Collins$11M
- Payal KohliAurora$1.7M
- Marc BonacaAurora$1.2M
- William SauerAurora$978K
- John AltmanLakewood$797K
- Nampalli VijayDenver$711K
- Brack HattlerAurora$699K
- Lin-Wang DongGreeley$640K
- Jake ChaninDenver$586K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.